Clinical Investigation| Volume 364, ISSUE 1, P29-35, July 2022

Psoriasis and pneumonia in the end-stage renal disease population



      Psoriasis is a common chronic inflammatory skin disease associated with an increased risk for acute infections. Because chronic kidney disease is a risk factor for pneumonia, end-stage renal disease (ESRD) patients with psoriasis may have an increased risk for acquiring pneumonia.

      Material and Methods

      A retrospective cohort analysis was performed using the United States Renal Data System, a medical claims database of all ESRD patients undergoing dialysis in the US. Logistic regression analysis was used to investigate the association of psoriasis with pneumonia in ESRD patients.


      A total of 6841 (0.7%) ESRD patients were diagnosed with psoriasis; 385,976 (36%) ESRD patients had pneumonia. Although simple models showed that psoriasis was associated with an increased risk of pneumonia in the ESRD population (odds ratio (OR) = 1.14), the final multivariable model found that psoriasis was protective for pneumonia (OR = 0.56) when controlling for age, race, sex, ethnicity, dialysis modality, Charlson Comorbidity Index (CCI), multiple sclerosis, tobacco use and alcohol use. This is due to both the CCI and tobacco use being strong confounders of the association of psoriasis and pneumonia. Black, other race and Hispanic ethnicity were also protective for pneumonia, while increasing age and CCI, female sex, hemodialysis, multiple sclerosis and tobacco and alcohol use were associated with increased risk.


      When controlling for multiple factors, psoriasis does not increase the risk for pneumonia in ESRD patients. In this cohort, other factors, such as the CCI and tobacco use, were more strongly associated with increased risk for pneumonia than psoriasis.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kurd SK
        • Gelfand JM.
        The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.
        J Am Acad Dermatol. 2009; 60: 218-224
        • Gudjonsson JE
        • Elder JT.
        Psoriasis: epidemiology.
        Clin Dermatol. 2007; 25: 535-546
        • Shinkai K
        • Fox LP.
        in: Papadakis M.A. McPhee S.J. Rabow M.W. Current Medical Diagnosis and Treatment 2020. McGraw-Hill, 2020
        • Menter A
        • Gottlieb A
        • Feldman SR
        • et al.
        Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
        J Am Acad Dermatol. 2008; 58: 826-850
        • Naldi L.
        Psoriasis and smoking: links and risks.
        Psoriasis (Auckl). 2016; 6: 65-71
        • Adamzik K
        • McAleer MA
        • Kirby B.
        Alcohol and psoriasis: sobering thoughts.
        Clin Exp Dermatol. 2013; 38: 819-822
        • Qureshi AA
        • Dominguez PL
        • Choi HK
        • et al.
        Alcohol intake and risk of incident psoriasis in US women: a prospective study.
        Arch Dermatol. 2010; 146: 1364-1369
        • Ni C
        • Chiu MW.
        Psoriasis and comorbidities: links and risks.
        Clin Cosmet Investig Dermatol. 2014; 7: 119-132
        • Mandell LA
        • Wunderink R.
        in: Jameson J Fauci A.S. Kasper D.L. Hauser S.L. Longo D.L. Loscalzo J Harrison's Principles of Internal Medicine, 20e. McGraw-Hill, 2018
        • Janssens JP
        • Krause KH
        Pneumonia in the very old.
        Lancet Infect Dis. 2004; 4: 112-124
        • Piatti G
        • Gazzola T
        • Allegra L
        Bacterial adherence in smokers and non-smokers.
        Pharmacol Res. 1997; 36: 481-484
        • Yeligar SM
        • Chen MM
        • Kovacs EJ
        • et al.
        Alcohol and lung injury and immunity.
        Alcohol. 2016; 55: 51-59
        • Kao LT
        • Lee CZ
        • Liu SP
        • Tsai MC
        • Lin HC.
        Psoriasis and the risk of pneumonia: a population-based study.
        PLoS One. 2014; 9e116077
        • Levey AS
        • Coresh J.
        Chronic kidney disease.
        Lancet. 2012; 379: 165-180
        • Schwade MJ
        • Tien L
        • Waller JL
        • et al.
        Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: a retrospective cohort study.
        Am J Med Sci. 2021;
        • Almirall J
        • Gonzalez J
        • Rello J
        • et al.
        Infection of hemodialysis catheters: incidence and mechanisms.
        Am J Nephrol. 1989; 9: 454-459
        • Stevenson KB
        • Hannah EL
        • Lowder CA
        • et al.
        Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access.
        Am J Kidney Dis. 2002; 39: 549-555
        • Betjes MG
        • Litjens NH.
        Chronic kidney disease and premature ageing of the adaptive immune response.
        Curr Urol Rep. 2015; 16: 471
        • Syed-Ahmed M
        • Narayanan M.
        Immune dysfunction and risk of infection in chronic kidney disease.
        Adv Chronic Kidney Dis. 2019; 26: 8-15
        • Menon TJ
        • Wroblewski BM.
        Charnley low-friction arthroplasty in patients with psoriasis.
        Clin Orthop Relat Res. 1983; : 127-128
        • Stern SH
        • Insall JN
        • Windsor RE
        • et al.
        Total knee arthroplasty in patients with psoriasis.
        Clin Orthop Relat Res. 1989; (discussion 11): 108-110
        • Lindegard B.
        Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes.
        Dermatologica. 1986; 172: 298-304
        • Drancourt M
        • Argenson JN
        • Tissot Dupont H
        • et al.
        Psoriasis is arisk factor for hip-prosthesis infection.
        Eur J Epidemiol. 1997; 13: 205-207
        • Wakkee M
        • de Vries E
        • van den Haak P
        • et al.
        Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort.
        J Am Acad Dermatol. 2011; 65: 1135-1144
        • Doherty SD
        • Van Voorhees A
        • Lebwohl MG
        • et al.
        National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.
        J Am Acad Dermatol. 2008; 59: 209-217
        • Charlson ME
        • Pompei P
        • Ales KL
        • et al.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • Deyo RA
        • Cherkin DC
        • Ciol MA.
        Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.
        J Clin Epidemiol. 1992; 45: 613-619
        • Sundararajan V
        • Henderson T
        • Perry C
        • et al.
        New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality.
        J Clin Epidemiol. 2004; 57: 1288-1294
        • Wan J
        • Wang S
        • Haynes K
        • et al.
        Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.
        BMJ. 2013; 347: f5961
        • Morhenn VB.
        The relationship of wound healing with psoriasis and multiple sclerosis.
        Adv Wound Care (New Rochelle). 2018; 7: 185-188
        • Oliveira M
        • Rocha B
        • Duarte GV.
        Psoriasis: classical and emerging comorbidities.
        Anais Brasil Dermatol. 2015; 90: 9-20
        • Guo H
        • Liu J
        • Collins AJ
        • et al.
        Pneumonia in incident dialysis patients–the United States renal data system.
        Nephrol Dial Transplant. 2008; 23: 680-686
        • Baik I
        • Curhan GC
        • Rimm EB
        • et al.
        A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women.
        Arch Int Med. 2000; 160: 3082-3088
        • Harding K
        • Zhu F
        • Alotaibi M
        • et al.
        Multiple cause of death analysis in multiple sclerosis: a population-based study.
        Neurology. 2020; 94: e820-ee29
        • Torres A
        • Peetermans WE
        • Viegi G
        • et al.
        Risk factors for community-acquired pneumonia in adults in Europe: a literature review.
        Thorax. 2013; 68: 1057-1065
        • Hsu CY
        • McCulloch CE
        • Darbinian J
        • Go AS
        • Iribarren C.
        Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
        Arch Intern Med. 2005; 165: 923-928
        • Pugh D
        • Gallacher PJ
        • Dhaun N.
        Management of hypertension in chronic kidney disease.
        Drugs. 2019; 79: 365-379
        • Armstrong AW
        • Harskamp CT
        • Armstrong EJ.
        The association between psoriasis and hypertension.
        J Hypertension. 2013; 31: 433-443
        • Takahashi T
        • Yamasaki K.
        Psoriasis and antimicrobial peptides.
        Int J Mol Sci. 2020; 21
        • Quan H
        • Li B
        • Saunders LD
        • et al.
        Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.
        Health Serv Res. 2008; 43: 1424-1441
        • Asgari MM
        • Wu JJ
        • Gelfand JM
        • et al.
        Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.
        Pharmacoepidemiol Drug Saf. 2013; 22: 842-849
        • Wiese AD
        • Griffin MR
        • Stein CM
        • et al.
        Validation of discharge diagnosis codes to identify serious infections among middle age and older adults.
        BMJ Open. 2018; 8e020857
        • Saran R
        • Robinson B
        • Abbott KC
        • et al.
        US renal data system 2016 annual data report: epidemiology of kidney disease in the United States.
        Am J Kidney Dis. 2017; 69: A7-A8